/Companies

Spotlight Pathology

10 known investors

Find your way into Spotlight Pathology

Sign up to see every warm intro you have to Spotlight Pathology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Spotlight Pathology team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services. The company serves diagnostic laboratories and healthcare centers by providing decision support systems underpinned by machine learning algorithms for image analysis.

Founders & leadership

M
MartinCo-Founder and Chief Technology Officer
R
RichardCo-Founder and Chief Medical Officer
SPSam Perona (Westgate)
Sam Perona (Westgate)Chief Executive OfficerSam Perona is Chief Executive Officer of Spotlight Pathology, an AI diagnostics company for pathology. He holds a PhD and MSc, and has commercial research experience including FDA 510(k) submissions and medical device regulatory compliance, along with completion of Goldman Sachs' 10,000 Small Businesses program.

Investors · 10

Also in the syndicate · 6

AXM Venture CapitalEHE VenturesLiverpool City Region Seed FundleadLyva LabsUK Innovation and Science Seed FundleadUKI2Slead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗
Registered name
SPOTLIGHT PATHOLOGY LTD
Company number
12435884
Status
Active
Company type
Private limited company
Incorporated
31 Jan 2020
Registered office
The Innovation Centre, Sci-Tech Daresbury Keckwick Lane, Daresbury, Warrington, Cheshire, WA4 4FS
Nature of business (SIC)
62012 — Business and domestic software development
Accounts
last made up to 31 Jan 2025 · next due 31 Oct 2026
Confirmation statement
last made up to 30 Jan 2026 · next due 13 Feb 2027

Current officers · 5

  • Richard John Byers — director, appointed 13 Oct 2021
  • Martin Paul Fergie — director, appointed 31 Jan 2020
  • Marcel Gehrung — director, appointed 30 Jan 2026
  • Samantha Jane Perona — director, appointed 30 Jan 2026
  • Andrew Edward Round — director, appointed 30 Jan 2026

Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Spotlight Pathology do?
Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services. The company serves diagnostic laboratories and healthcare centers by providing decision support systems underpinned by machine learning algorithms for image analysis.
Who founded Spotlight Pathology?
Spotlight Pathology was founded by Martin, Richard.
Who are Spotlight Pathology's investors?
Spotlight Pathology's investors include Deepbridge Capital, UK Innovation & Science Seed Fund, Future Planet Capital, River Capital.